AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05678829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: The trainings for the Virtual Reality group will continue in accordance with the training titles according to the weeks, using virtual reality glasses.
Study NCT05987709 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: GuardantSHIELD Blood Test
Description: The GuardantSHIELD CRC screening test is a commercially available test which works by finding signs of colorectal tumor in the blood of patients at average risk for CRC
Study NCT04487457 — intervention group
Intervention type: OTHER
Intervention: Blood samples
Description: Blood samples
Study NCT06319300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-assisted insulin dose adjustment model
Description: We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients
Study NCT06319300 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: doctor's insulin dose adjustment
Description: participants' insulin doses are adjusted by doctors
Study NCT05865548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin 150 mg
Description: Aspirin 150 mg PO daily
Study NCT05865548 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Surgery with or without radiation, palliative chemo as per investigators choice
Study NCT04784988 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EHL-FVIII
Description: prophylaxis with EHL-FVIII targeting a 12% FVIII through level based on PK assessment with WAPPS-Hemo
Study NCT04784988 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FVIII concentrate
Description: standard prophylaxis with FVIII concentrate according to current guidelines
Study NCT05995158 — intervention group
Intervention type: PROCEDURE
Intervention: Metagenomic testing of the subgingival plaque samples
Description: sampling, extraction and sequencing of the oral microbiome in the samples
Study NCT06140888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ginkgo Biloba Extract
Description: Ginkgo biloba extract 8 pills three times per day is administrated.
Study NCT04759768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalmefene Hydrochloride
Description: 3mg nasal spray
Study NCT04759768 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nalmefene
Description: 1mg intramuscular injection
Study NCT06364514 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Stability Assessment
Description: Base total days of antibiotics on clinical stability vs utilizing predetermined total days of antibiotics
Study NCT05073822 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tacrolimus
Description: reduction of both standard Tacrolimus \& Mycophenolate mofetil does in one arm
Study NCT05727111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) implemented at the patient home
Description: The HABIT-ILE therapy at home will follow the same principles as the classic HABIT-ILE. The therapy will take place in the patient's home and a close person (caregiver) will accompany the patient during the therapy. A device will be used to facilitate the implementation of home therapy. Supervision of the therapeutic process will be done remotely by a team of trained supervisors. One hour of remote supervision per day will be scheduled within 6.5 hours of therapy.
Study NCT05727111 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)
Description: HABIT-ILE (Hand-Arm Bimanual Intensive Therapy including Lower Extremities) is an intensive therapy that continuously incorporates postural control and LE function. This motor learning-based approach include specificity of the practice, motivation, shaping of the task, intensive blocks of training and Hands-Off. Moreover, the therapy is goal-oriented to increase functional independence during daily living.
Study NCT05727111 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Follow-up Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) at the patient's home
Description: HABIT-ILE follow-up at home follow the same principles as classic HABIT-ILE but is delivered at the patient home with 1 hour per day (4 hours per week in autonomy and 1 hour per week under supervision).
Study NCT05727111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Follow-up Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) at the patient's home
Description: HABIT-ILE follow-up at home follow the same principles as classic HABIT-ILE but is delivered at the patient home with 1 hour per day (4 hours per week in autonomy and 1 hour per week under supervision).
Study NCT05727111 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care is all the weekly physiotherapy and occupational therapy sessions that the patient usually receives.
Study NCT05727111 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Usual care is all the weekly physiotherapy and occupational therapy sessions that the patient usually receives.
Study NCT05197452 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Testing
Description: For in-person PCR testing, a nasal swab will be inserted shallowly into the participant's nose and rotated in each nostril. The swab will be broken off into a designated test tube and placed into a specimen bag along with a label. All specimens will be stored in a cooler until they are transported the Rush Laboratory for COVID-19 analysis.~For at home antigen testing, participants will download an app to their mobile phone and watch an informational video. The test will be self-administered by inserting a nasal swab into the nostril until a cap containing the swab touches the nose; rubbing the swab tip around the nose cavity 3 times; removing the swab and repeating in the other nostril. The nasal swab, a dropper, processing fluid, and a blue tooth connected analyzer are provided with the testing kit to analyze the sample for COVID-19. COVID-19 home test results are displayed on the participants smart phone after 15 minutes.
Study NCT05482711 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Time Restricted Eating Intervention
Description: All participants will be asked to adhere to suggested fasting and feeding periods throughout the 8 week study period. These participants will self-monitor eating and sleeping habits as well to present to study staff at checkpoints. Self-reported information will be used during group-mediated intervention sessions throughout the duration of the study, as well.
Study NCT00012688 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Doxycycline HCI 10mg po for 2 weeks
Study NCT00012688 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Ultrasonic scaling with 0.12% chlorhexidine gluconate
Study NCT05391867 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Tyrosine kinase inhibitor
Study NCT06509594 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Protocol of Scapular Stabilization Exercises;
Description: Exercise for the middle trapezius and rhomboid muscles: Participants were instructed to stand with their arms hanging beside their bodies. Then, they were instructed to flex their elbows 90◦ holding an elastic band and performing an external rotation of the shoulder, pulling both scapula together. Subsequently, they returned to a neutral shoulder position with elbow flexion.~Exercise for the lower trapezius muscle: Participants were instructed to lie down in a prone position while holding an elastic band attached at one end under a mattress. They were then instructed to raise their shoulder 140◦.~Exercise for the serratus anterior muscle: Participants were instructed to stand and flex their elbows 90◦ while holding an elastic band fixed behind the participants. Next, they were instructed to move the arm forward with a protracted scapula.
Study NCT06509594 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Protocol of Muscle Energy technique;
Description: During upper trapezius stretching, the participants were in seated position by holding the chair with one arm, and laterally tilted the head to the opposite side with the other hand pushing the head to increase lateral stretch.~For pectoralis muscle stretch, participants were asked to stand in front of the Doorframe with elbow bent at 90 degree and was asked to lean forward without Taking a step forward. The stretch is felt across the anterior chest, which is held for 15-30 seconds with 2-3 repetitions. For levator scapulae stretch, the subjects were asked to take the seated position while holding the chair with one hand in order to maintain shoulder depression, then To flex and rotate neck to the opposite side by placing the other hand at the back of their head and to slowly pull it down toward the armpit.
Study NCT05067582 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L1-79
Description: tyrosine hydroxylase inhibitor
Study NCT04755309 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rhythmic intervention
Description: The rhythmic intervention consists in an ecological and non-invasive intervention based on enriched auditory and musical active experience. It is based on the most recent scientific evidence in the field and provides exposure to and active synchronization with complex musical rhythms. It is thought to promote the infant's ability to recognize and process the complex rhythms of spoken language. Importantly, it taps into and empowers early auditory processing skills. The intervention includes several tasks described in the literature, for example tapping and bouncing at the beat of complex musical rhythms.~The intervention takes place in small groups of infant-caregiver pairs (N=4/5) for 1 hour/week for 6 weeks.
Study NCT04755309 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Passive auditory stimulation
Description: The same auditory stimulation is provided to infants, but no active tasks are proposed. Children and caregiver are entertained with motor and cognitive tasks not related to the auditory stimuli presented. The intervention takes place in small groups of infant-caregiver pairs (N=4/5) for 1 hour/week for 6 weeks.
Study NCT05067582 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: L1-79
Description: tyrosine hydroxylase inhibitor
Study NCT04728035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan Liposome Injection
Description: Irinotecan Liposome Injection
Study NCT04998266 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Performing following WHO (World Health Organization)
Description: The CLA group will perform exercises following WHO (World Health Organization) prescription
Study NCT04998266 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Performing on their needs
Description: The IND group will perform strength, aerobic or flexibility exercises depending on their needs observed during the first assessment.
Study NCT05629390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lotilaner
Description: Lotilaner Ophthalmic Solution
Study NCT05629390 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Control
Description: Vehicle of TP-03 ophthalmic solution
Study NCT05308888 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET-CT
Description: The 18F-FDG PET-CT will be performed in the nuclear medicine department of the CHU of Brest. For this exam, the administration of 2-3 MBq/kg of 18F-FDG (\[18F\]F-fluorodeoxyglucose) will be performed to the patient in a single intravenous injection.
Study NCT05634551 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Participants will complete 5 questionnaires about any symptoms participants may be having, any anxiety and/or depression participants may be having, your preference in decision-making, and your expectations about your treatment. It should take about 30 minutes to complete all 5 questionnaires
Study NCT05634551 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interview
Description: The interview will last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom or FaceTime (based on your preference)
Study NCT05228431 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX
Description: Starting from the first day of radiotherapy (set as day 0), the patient received a total of 4 courses of XELOX chemotherapy on days -42, -21, 42, and 63, including oxaliplatin 130 mg/m2, intravenous administration, d1, repeat every 3 weeks; and capecitabine 1000mg/m2, twice daily, d1-d14, repeat every 3 weeks.
Study NCT05228431 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine monotherapy
Description: During radiotherapy (Monday to Friday), capecitabine was administered at 1650 mg/m2/d, twice a day.
Study NCT05228431 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: The TV is expanded by 6-7mm to form PTV1, and the CTV is expanded by 6-7mm to form PTV2. The dose of PTV1 was 50Gy/25 times/35 days, and the dose of PTV2 was 45Gy/25 times/35 days, 5 times/week for a total of 5 weeks.
Study NCT05088785 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FES
Description: \[18F\]FES PET imaging.
Study NCT05441501 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-80038114
Description: JNJ-80038114 will be administered.
Study NCT05270681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Movement to Music
Description: Participants will be educated on how to access prerecorded Move to Improve classes conducted by a professional dance instructor which will be accessible by computer or tablet 24/7 via a hyperlink. Classes last 45 minutes, and participants will be instructed to participate in the activity at least twice weekly, for 12 weeks. Each class uses movement to music combinations across different dance genres that build in intensity and sequence complexity, accompanied by music with faster beats, to encourage participants to achieve a moderate-vigorous level of physical and cognitive activity. Care partners will be present during each class to ensure safety and will also participate in the Move to Improve exercise program. The care partner and participant will be instructed to stand at a counter or behind a chair for safety during exercise.
Study NCT05790603 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention group with PHD-Band
Description: The initial compression pressure was systolic blood pressure plus 10mmHg. Pressure will be released by 20mmHg and 40mmHg 1 hour and 2 hours respectively after the surgery and then the band will be removed after 3 hours if no bleeding occurs. The compression will continue if bleeding occurs.
Study NCT05325879 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: VAGUS-NDT
Description: Neurodynamic test for vagus nerve
Study NCT05325879 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VAGUS-NDT
Description: Neurodynamic test for vagus nerve
Study NCT04690543 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: z-plasty
Description: Z-plasty: It will be defined as a local transposition flap that will be used to improve the functional and cosmetic appearance of scars. It will be involved creating two triangular flaps of equal dimensions that will be transposed.
Study NCT04690543 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: square flap
Description: Square flap: It will be defined as is another local transposition flap which will be used for release of contractures. Square will be marked on one side of the contracture, and two triangles will be marked on the other side, with the length of all the flaps equal, which will be then transposed.
Study NCT05072561 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node scintigraphy
Description: During the surgery, right after the identification of the primary, 18-37 MBq of 99mTc-Nanocolloids in two ml will be injected at four peritumoral locations. After a brief waiting time (5-10'), the thoracic surgeon will perform the clinical intervention, including the lobectomy (the injection sites will be resected alongside the tumour) and lymphadenectomy, according to the best clinical practice. All the excised lymph nodes will be ex vivo counted using a gamma probe: those with a detectable activity (at least 10% of the hottest lymph node) will be considered as SLN. Thereafter, the mediastinum will be scanned using the gamma probe and a handheld gamma-camera (the latter will not be employed in case of robotic-assisted surgery); any further source of radioactivity will be investigated and, should further lymph nodes be identified, these will be also resected and classified in SLN or non-SLN, based on ex vivo activity.
Study NCT04554277 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biomarker guided therapy
Description: Guided therapy using sST-2 monitoring at the discharge from initial hospitalisation, 6, 12, 18 and 24 months of following.
Study NCT05352893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imsidolimab high dose
Description: intravenous
Study NCT05352893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imsidolimab low dose
Description: intravenous
Study NCT05352893 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: intravenous
Study NCT03980457 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Indego Exoskeleton
Description: Powered generated orthosis
Study NCT03980457 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Rehabilitation
Description: Standard Rehabilitation
Study NCT03980457 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Rehabilitation
Description: Standard Rehabilitation
Study NCT05759442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin Hydrochloride (HCL)
Description: Tab Metformin HCL 500mg twice per day aimed at improving glycemic indices in Prediabetics
Study NCT05759442 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Apple cider vinegar
Description: Apple cider vinegar aimed at improving glycemic indices in Prediabetics
Study NCT05371574 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: clonidine group
Description: Each participant will be receive 0.2mg of oral clonidine 60 minutes before surgery and 10mls of sterile water (placebo) 10 minutes after skin incision
Study NCT04711473 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Colonoscopy Only
Description: Mailed letter asking participants to complete CRC screening by colonoscopy
Study NCT04711473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choice
Description: Mailed letter and FIT test asking participants to complete CRC screening by their choice of either colonoscopy or mailed FIT
Study NCT04711473 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FIT Only
Description: Mailed letter and FIT test asking participants to complete CRC screening by mailed FIT
Study NCT05790603 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control group with TR-Band
Description: TR-Band will be inflated with 15 mL of air The band will be deflated with 1 mL of air hourly for the following 2 hours after the procedure. After 3 hours, the band will be removed if no bleeding occurs. If rebleeding occurs, the band will be inflated with appropriate volume of air until bleeding stops .
Study NCT04939220 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TEE with SGA
Description: SGA Placement and maintenance with inhalational anesthetic or propofol
Study NCT04939220 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TEE with Deep Sedation
Description: Deep sedation with propofol and natural airway
Study NCT04033029 — intervention group
Intervention type: DEVICE
Intervention: Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®)
Description: CRRT initiation will be determined by the treating physician on charge, according with the current recommendations of clinical practice and prescriptions of CRRT and local management protocols. The CVVHDF mode will be performed by using PrismafleX eXeed™ system and high adsorbent polyethyleneimide membrane (oXiris®). Filtration parameters will be determined following the local protocol (dose of 25-30 ml/kg/h).
Study NCT04825067 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Respiratory Sensor measurements
Description: The participant will receive 2 Respiratory Sensors and 1 gateway with wireless compatibility and a welcome packet with instructions for use, a reminder description of the study purpose and procedures, and research staff contact information. Research staff will contact participants to ensure appropriate setup of the Respiratory Sensor and training on proper use. Research staff will ask the subject to place the Respiratory Sensor on the top left-side of the chest. The Respiratory Sensor continuously collects and monitors respiratory data. The participant will be instructed to change each Respiratory Sensor after 24-48 hours. Subjects will be asked to charge each Respiratory Sensor once it is removed. Subjects will exit the study upon completion of the 90-day follow-up.
Study NCT05733273 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nordic hamstring exercise program
Description: Week 1 - 1 session per week consisting of 2 sets of 5 reps of the exercise Week 2 - 2 sessions per week consisting of 2 sets of 6 reps of the exercise Week 3 -3 sessions per week consisting of 3 sets of 6 reps of the exercise Week 4 - 3 sessions per week consisting of 3 sets of 8 reps of the exercise Weeks 5 and 6 - 3 sessions per week consisting of 3 sets of the exercise. Set 1 with 12 reps, set 2 with 10 reps and set 3 with 8 reps